Use of Self-management Group to Improve Quality of Life in Patients With Low Vision

A Randomized Controlled Trial to Assess if Attending an Interactive, Self-management Group, 'Living With Vision Loss', in Addition to Having Vision Rehabilitation in Our Clinic, Improves Patients' Quality of Life

Status

Withdrawn

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03046485

Enrollment

Registered

2017-02-08

Start date

2007-05-31

Completion date

2016-12-31

Last updated

2017-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age Related Macular Degeneration

Keywords

AMD, vision loss, self-management strategies, low-vision rehabilitation, IVI

Brief summary

120 Patients with visual acuity \<6/12 will be randomized to receive either usual care or participate in a 6-week, 2 hour 'Living with Vision Loss' program led by trained leaders. We hypothesize that a structured self-management low-vision rehabilitation program provides a greater improvement in participation in daily activities, and improves quality of life in vision-impaired people compared to the provision of the usual low vision rehabilitation services. We also plan to document barriers that prevent patients with low vision (visual acuity \<6/12) from participating in self-management course.

Interventions

BEHAVIORALSelf management program 'Living with Vision Loss'

group met for 6 weeks, 2 hours per week, to discuss strategies for living with low vision

Study design

Allocation

RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

55 Years to 95 Years

Healthy volunteers

Yes

Inclusion criteria

* Clients who have attended the MEEI Vision Rehabilitation for the first time within 12 months * Visual acuity of \<6/12 in the better eye with habitual correction * Age 55+ years * Living independently (not in a nursing home) * English speaking * No cognitive impairment * Adequate hearing to respond to normal conversation

Exclusion criteria

* vestibular disease

Design outcomes

Primary

Measure	Time frame
Impact of Vision Impairment Questionnaire (IVI)	1 year

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026